Entrada Therapeutics (TRDA) FCF Margin (2023 - 2026)
Entrada Therapeutics' FCF Margin came in at -3616.26% for Q2 2026, down 2089.90 percentage points from -1526.36% a year earlier but up 1153.91 percentage points from the prior quarter.
Powered by 
Analysis
Entrada Therapeutics (TRDA) FCF Margin (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Entrada Therapeutics reported FCF Margin of -2867.07%, down 2707.83 percentage points year-over-year; for FY2025, it was -509.63%, down 488.42 percentage points from FY2024.
- Going back by year, FCF Margin was -21.21% in FY2024 (-125.23 pp) and 104.01% in FY2023.
- The five-year range for quarterly FCF Margin is -4770.17% (Q1 2026) to 798.62% (Q1 2023).
- Year-over-year, FCF Margin has declined for eight consecutive quarters, with an average year-over-year change of -1564.79 percentage points over the last eight quarters.
- The fastest year-over-year change in FCF Margin over five years came in Q2 2024 (a gain of 242.46 percentage points), and the weakest in Q1 2026 (a drop of 4577.30 percentage points).
- Business Quant data shows TRDA's FCF Margin at -4770.17% (Q1 2026), -2463.13% (Q4 2025) and -1743.62% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | Entrada Therapeutics | 242.19 Mn | 242.19 Mn | - | -3,616.26% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3,616.26% |
| Mar 31, 2026 | -4,770.17% |
| Dec 31, 2025 | -2,463.13% |
| Sep 30, 2025 | -1,743.62% |
| Jun 30, 2025 | -1,526.36% |
| Mar 31, 2025 | -192.87% |
| Dec 31, 2024 | -86.21% |
| Sep 30, 2024 | -127.26% |
| Jun 30, 2024 | 40.96% |
| Mar 31, 2024 | -44.58% |
| Dec 31, 2023 | -11.92% |
| Sep 30, 2023 | -59.31% |
| Jun 30, 2023 | -201.50% |
| Mar 31, 2023 | 798.62% |
API Access
Entrada Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=TRDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "TRDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=TRDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();